Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Completed · Phase 2
Conditions studied: Leukemia, Myelocytic, Acute, Leukemia, Blood and Marrow Transplant (BMT)
In brief
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.
Key facts
- Study ID
- NCT00186381
- Run by
- Stanford University
- People needed
- 200
- Starts
- 1995-11-01
- Expected to finish
- 2007-03-01
- Last updated by the study team
- 2010-07-27
Who can join
Age: 16 and older, up to 69. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.